review competing claims patent trademark office determine invented technology unclear way result says mari serebrov regulatory editor thomson reuters bioworld courts rule technology not patentable chill investment hand group allowed patent result monopoly probably licenses expensive discourage research patents lock field depending broadly written uncertainty lull says people wait battle pans biotech giant monsanto limited crispr applications decision greg aharorian director center global innovation patent metrics believes dispute will not impact science r&d warns longer patent battle continues deal greater chance new types gene editing discovered potentially undercut future profits crispr proves useful adds people money 4 hours ago robin